Catheter-Related InfectionsSubstance Withdrawal SyndromeCross InfectionBenzodiazepinesSafety-Based Drug WithdrawalsFlumazenilAnticonvulsantsMorphine DependenceFlunitrazepamDiazepamReceptors, GABA-AAnti-Anxiety AgentsBenzodiazepinonesGABA ModulatorsMorphineSafetySeizuresFlurazepamEpilepsyLorazepamDrug-Related Side Effects and Adverse ReactionsCarbolinesTime FactorsDrug Administration ScheduleGABA-A Receptor AgonistsBehavior, AnimalRats, Sprague-DawleyRecurrenceImmunosuppressive AgentsDose-Response Relationship, DrugClonazepamMidazolamTreatment OutcomeChlordiazepoxideHypnotics and SedativesSafety ManagementAlprazolamIsoquinolinesTriazolamPatient SafetyGABA-A Receptor AntagonistsConvulsantsFollow-Up StudiesNitrazepamAlcohol Withdrawal DeliriumNordazepamAlcohol Withdrawal SeizuresMuscimolOxazepamDiazepam Binding InhibitorPentylenetetrazoleTemazepamHealth PersonnelDelivery of Health Caregamma-Aminobutyric AcidGABA AgonistsDrug ToleranceBrainPentobarbitalPregnanoloneEthanolReceptors, GABAUnited StatesPyridazinesClorazepate DipotassiumAnxietyBarbituratesNaloxoneFood SafetyUnited States Agency for Healthcare Research and QualityDouble-Blind MethodMedical ErrorsWithholding TreatmentAzabicyclo CompoundsHealth Care CostsRadioligand AssayHealthcare DisparitiesDrug UtilizationCatatoniaEquipment SafetyQuestionnairesPyridinesAttitude of Health PersonnelDrug InteractionsPicrotoxinOrganizational CultureCerebral CortexSubstance-Related DisordersRats, Inbred StrainsReceptors, DrugCentral Nervous System DepressantsEnzyme Multiplied Immunoassay TechniqueLigandsRats, WistarGABA AntagonistsSleep Initiation and Maintenance DisordersConsumer Product SafetyBrain ChemistryAutoradiographyQuality of Health Care